C
CHRS
Coherus
1.425
-0.035-2.40%Opening15:31 08/28 EDT
OPEN/PREV CLOSE1.450/1.460
TODAY RANGE1.405-1.480
VOL387.74K
MARKET CAP220.16M
52 WEEK RANGE1.090-2.616
AVG VOL (3M)1.01M
% TURNOVER0.25%
TURNOVER--
P/E (TTM)-1.3800
% RANGE5.14%
EPS(TTM)-1.0326
P/E(FORWARD)-1.7162
P/B3.619
BVPS0.3938
DIVIDEND--
P/S4.094
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP173.70M
SHARES OUTSTANDING154.50M
NEXT EARNINGS11/04-11/09
FREE FLOAT121.89M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
Seeking Alpha·08/19 17:48
Coherus: 'Hold' On Several Tagmokitug 2026 Catalysts And Casdozokitug HCC Drug Development
TipRanks·08/18 00:12
Coherus Earnings Call: Oncology Focus, Cash Trade‑Offs
TipRanks·08/17 21:47
Coherus Biosciences Secures New Term Loan, Refinances Debt
TipRanks·08/17 21:47
Coherus Biosciences Issues Contingent Value Rights Dividend
TipRanks·08/17 21:40
Coherus Oncology issuing special dividend of biosimilar contingent value rights
Dow Jones·08/17 21:33
Press Release: Coherus Oncology Announces Special -2-
Dow Jones·08/07 17:19
Coherus Oncology Is Maintained at Buy by Guggenheim
Dow Jones·08/07 17:19
Coherus Oncology Price Target Cut to $10.00/Share From $12.00 by Guggenheim
Benzinga·08/07 17:08
Guggenheim Maintains Buy on Coherus Oncology, Lowers Price Target to $10
TipRanks·08/07 11:46
Coherus Oncology price target lowered to $10 from $12 at Guggenheim
TipRanks·08/05 22:40
Coherus Oncology reports Q2 EPS (19c), consensus (12c)
Seeking Alpha·08/05 21:30
Coherus BioSciences Non-GAAP EPS of -$0.19 misses by $0.07, revenue of $14.31M misses by $6.13M
Same Industry
Name/Symbol
Change%
Price